Bisphosphonate protonation states, conformations, and dynamics on bone mineral probed by solid-state NMR without isotope enrichment
- PMID: 20554022
- DOI: 10.1016/j.ejpb.2010.05.013
Bisphosphonate protonation states, conformations, and dynamics on bone mineral probed by solid-state NMR without isotope enrichment
Abstract
Recognition of bone mineral by bisphosphonates is crucial to their targeting, efficacy, therapeutic and diagnostic applications, and pharmacokinetics. In a search for rapid and simple NMR approaches to assessing the bone recognition characteristics of bisphosphonates, we have studied alendronate, pamidronate, neridronate, zoledronate and tiludronate, in crystalline form and bound to the surface of pure bone mineral stripped of its organic matrix by a simple chemical process. (31)P NMR chemical shift anisotropies and asymmetries in the crystalline compounds cluster strongly into groupings corresponding to fully protonated, monoprotonated, and deprotonated phosphonate states. All the mineral-bound bisphosphonates cluster in the same anisotropy-asymmetry space as the deprotonated phosphonates. In (13)C{(31)P} rotational echo double resonance (REDOR) experiments, which are sensitive to carbon-phosphorus interatomic distances, the strongly mineral-bound alendronate displays very similar conformational and side chain dynamics to its crystalline state. Pamidronate and neridronate, with shorter and longer sidechains, respectively, and generally weaker mineral binding, display more dynamical sidechains in the mineral-bound state. The REDOR experiment provides a simple rationalization of bisphosphonate-mineral affinity in terms of molecular structure and dynamics, consistent with findings from much more labour- and time-intensive isotope labelling approaches.
2010 Elsevier B.V. All rights reserved.
Similar articles
-
NMR investigations of the static and dynamic structures of bisphosphonates on human bone: a molecular model.J Am Chem Soc. 2008 Jan 30;130(4):1264-73. doi: 10.1021/ja0759949. Epub 2008 Jan 4. J Am Chem Soc. 2008. PMID: 18173269
-
Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite.Bone. 2006 May;38(5):617-27. doi: 10.1016/j.bone.2005.05.003. Epub 2005 Jul 20. Bone. 2006. PMID: 16046206
-
A quantitative structure-activity relationship and pharmacophore modeling investigation of aryl-X and heterocyclic bisphosphonates as bone resorption agents.J Med Chem. 2003 Jul 3;46(14):2932-44. doi: 10.1021/jm030054u. J Med Chem. 2003. PMID: 12825934
-
Determination of bisphosphonate active pharmaceutical ingredients in pharmaceuticals and biological material: a review of analytical methods.J Pharm Biomed Anal. 2008 Nov 4;48(3):483-96. doi: 10.1016/j.jpba.2008.05.028. Epub 2008 Jul 2. J Pharm Biomed Anal. 2008. PMID: 18599247 Review.
-
Optimizing the management of postmenopausal osteoporosis with bisphosphonates: the emerging role of intermittent therapy.Clin Ther. 2005 Apr;27(4):361-76. doi: 10.1016/j.clinthera.2005.04.005. Clin Ther. 2005. PMID: 15922811 Review.
Cited by
-
Structural requirements for bisphosphonate binding on hydroxyapatite: NMR study of bisphosphonate partial esters.ACS Med Chem Lett. 2015 Feb 21;6(4):397-401. doi: 10.1021/ml5004603. eCollection 2015 Apr 9. ACS Med Chem Lett. 2015. PMID: 25893039 Free PMC article.
-
Smart, programmable and responsive injectable hydrogels for controlled release of cargo osteoporosis drugs.Sci Rep. 2017 Jul 6;7(1):4743. doi: 10.1038/s41598-017-04956-3. Sci Rep. 2017. PMID: 28684783 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical